MBOT Valuation

Microbot Medical Inc

Add to Watchlist

Advanced Chart

3.090

-0.04(-1.278%)1D

Overview
Forecast
Valuation
Earnings

MBOT Relative Valuation

MBOT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MBOT is overvalued; if below, it's undervalued.

Historical Valuation

Microbot Medical Inc (MBOT) is now in the Fair zone, suggesting that its current forward PS ratio of 15.01 is considered Fairly compared with the five-year average of -3.50. The fair price of Microbot Medical Inc (MBOT) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：3.09

Fair

-11.04

Trailing

Forward

0.00

EV/EBITDA

Microbot Medical Inc. (MBOT) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.

-11.10

EV/EBIT

Microbot Medical Inc. (MBOT) has a current EV/EBIT of -11.10. The 5-year average EV/EBIT is -2.18. The thresholds are as follows: Strongly Undervalued below -5.16, Undervalued between -5.16 and -3.67, Fairly Valued between -0.69 and -3.67, Overvalued between -0.69 and 0.80, and Strongly Overvalued above 0.80. The current Forward EV/EBIT of -11.10 falls within the Strongly Undervalued range.

15.01

Microbot Medical Inc. (MBOT) has a current PS of 15.01. The 5-year average PS is 810.97. The thresholds are as follows: Strongly Undervalued below -8322.05, Undervalued between -8322.05 and -3755.54, Fairly Valued between 5377.49 and -3755.54, Overvalued between 5377.49 and 9944.00, and Strongly Overvalued above 9944.00. The current Forward PS of 15.01 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

Microbot Medical Inc. (MBOT) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.

0.00

P/FCF

Microbot Medical Inc. (MBOT) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.

Microbot Medical Inc (MBOT) has a current Price-to-Book (P/B) ratio of 3.86. Compared to its 3-year average P/B ratio of 3.79 , the current P/B ratio is approximately 2.02% higher. Relative to its 5-year average P/B ratio of 3.34, the current P/B ratio is about 15.70% higher. Microbot Medical Inc (MBOT) has a Forward Free Cash Flow (FCF) yield of approximately -6.96%. Compared to its 3-year average FCF yield of -44.15%, the current FCF yield is approximately -84.23% lower. Relative to its 5-year average FCF yield of -33.71% , the current FCF yield is about -79.34% lower.

3.86

P/B

Median3y

3.79

Median5y

3.34

-6.96

FCF Yield

Median3y

-44.15

Median5y

-33.71

Competitors Valuation Multiple

The average P/S ratio for MBOT's competitors is 7.37, providing a benchmark for relative valuation. Microbot Medical Inc Corp (MBOT) exhibits a P/S ratio of 15.01, which is 103.50% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Forte Biosciences Inc

Loss

143.85M

ONCY.O

Oncolytics Biotech Inc

Seres Therapeutics Inc

25.12

146.11M

Performance Decomposition

Market capitalization of MBOT increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of MBOT in the past 1 year is driven by Unknown.